These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8328984)
1. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984 [TBL] [Abstract][Full Text] [Related]
2. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model. Ashani Y; Pistinner S Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276 [TBL] [Abstract][Full Text] [Related]
3. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822 [TBL] [Abstract][Full Text] [Related]
4. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953 [TBL] [Abstract][Full Text] [Related]
5. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. Saxena A; Sun W; Luo C; Doctor BP Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104 [TBL] [Abstract][Full Text] [Related]
6. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds. Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396 [TBL] [Abstract][Full Text] [Related]
7. Human plasma-derived butyrylcholinesterase is behaviorally safe and effective in cynomolgus macaques (Macaca fascicularis) challenged with soman. Myers TM Chem Biol Interact; 2019 Aug; 308():170-178. PubMed ID: 31129133 [TBL] [Abstract][Full Text] [Related]
8. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication. Harris LW; Talbot BG; Lennox WJ; Anderson DR; Solana RP Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706 [TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs. Rosenberg Y; Saxena A Neuropharmacology; 2020 Sep; 174():108150. PubMed ID: 32442543 [TBL] [Abstract][Full Text] [Related]
11. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats. Genovese RF; Sun W; Johnson CC; Ditargiani RC; Doctor BP; Saxena A Basic Clin Pharmacol Toxicol; 2010 May; 106(5):428-34. PubMed ID: 20050840 [TBL] [Abstract][Full Text] [Related]
12. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX. Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507 [TBL] [Abstract][Full Text] [Related]
13. Role of carboxylesterase in soman, sarin and tabun poisoning in rats. Jokanović M Pharmacol Toxicol; 1989 Sep; 65(3):181-4. PubMed ID: 2813290 [TBL] [Abstract][Full Text] [Related]
14. A 10-minute point-of-care assay for detection of blood protein adducts resulting from low level exposure to organophosphate nerve agents. VanDine R; Babu UM; Condon P; Mendez A; Sambursky R Chem Biol Interact; 2013 Mar; 203(1):108-12. PubMed ID: 23200942 [TBL] [Abstract][Full Text] [Related]
15. The influence of inhibitors and other factors on cholinesterases. Bajgar J Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1991; 34(1):5-77. PubMed ID: 1759111 [TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Ashani Y; Shapira S; Levy D; Wolfe AD; Doctor BP; Raveh L Biochem Pharmacol; 1991 Jan; 41(1):37-41. PubMed ID: 1986743 [TBL] [Abstract][Full Text] [Related]
17. The inhibition, reactivation and mechanism of VX-, sarin-, fluoro-VX and fluoro-sarin surrogates following their interaction with HuAChE and HuBuChE. Chao CK; Balasubramanian N; Gerdes JM; Thompson CM Chem Biol Interact; 2018 Aug; 291():220-227. PubMed ID: 29920286 [TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase. Barakat NH; Zheng X; Gilley CB; MacDonald M; Okolotowicz K; Cashman JR; Vyas S; Beck JM; Hadad CM; Zhang J Chem Res Toxicol; 2009 Oct; 22(10):1669-79. PubMed ID: 19715346 [TBL] [Abstract][Full Text] [Related]
19. The effect of fluoride on the scavenging of organophosphates by human butyrylcholinesterase in buffer solutions and human plasma. Ashani Y; Segev O; Balan A Toxicol Appl Pharmacol; 2004 Jan; 194(1):90-9. PubMed ID: 14728983 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of an oximate-based skin decontaminant against organophosphate nerve agents determined in vivo and in vitro. Sawyer TW; Parker D; Thomas N; Weiss MT; Bide RW Toxicology; 1991 May; 67(3):267-77. PubMed ID: 2048130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]